Italy · Delayed Price · Currency is EUR AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of EUR 333.95 billion. The enterprise value is 389.58 billion.
| Market Cap | 333.95B |
| Enterprise Value | 389.58B |
Important Dates
The last earnings date was Friday, October 31, 2025.
| Earnings Date | Oct 31, 2025 |
| Ex-Dividend Date | Oct 14, 2025 |
Share Statistics
| Current Share Class | 1.77B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 73.82% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 166.88 and the forward PE ratio is 16.06.
| PE Ratio | 166.88 |
| Forward PE | 16.06 |
| PS Ratio | 6.57 |
| PB Ratio | -2,839.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 194.67 |
| EV / Sales | 7.53 |
| EV / EBITDA | 15.58 |
| EV / EBIT | 22.19 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.45 |
| Debt / FCF | n/a |
| Interest Coverage | 6.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 17.12% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 924,265 |
| Profits Per Employee | 36,385 |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -626.44M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.74% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +3.74% |
| 50-Day Moving Average | 190.13 |
| 200-Day Moving Average | 176.87 |
| Relative Strength Index (RSI) | 42.44 |
| Average Volume (20 Days) | 86 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.39 |
Income Statement
In the last 12 months, AbbVie had revenue of EUR 50.83 billion and earned 2.00 billion in profits. Earnings per share was 1.13.
| Revenue | 50.83B |
| Gross Profit | 36.19B |
| Operating Income | 17.26B |
| Pretax Income | 1.41B |
| Net Income | 2.00B |
| EBITDA | 24.29B |
| EBIT | 17.26B |
| Earnings Per Share (EPS) | 1.13 |
Balance Sheet
The company has 5.51 billion in cash and 60.16 billion in debt, giving a net cash position of -54.65 billion.
| Cash & Cash Equivalents | 5.51B |
| Total Debt | 60.16B |
| Net Cash | -54.65B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -117.62M |
| Book Value Per Share | -0.09 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.20%, with operating and profit margins of 33.95% and 4.00%.
| Gross Margin | 71.20% |
| Operating Margin | 33.95% |
| Pretax Margin | 2.78% |
| Profit Margin | 4.00% |
| EBITDA Margin | 47.78% |
| EBIT Margin | 33.95% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.27, which amounts to a dividend yield of 2.25%.
| Dividend Per Share | 4.27 |
| Dividend Yield | 2.25% |
| Dividend Growth (YoY) | -25.18% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 2.25% |
| Earnings Yield | 0.60% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |